Ghulam Rehman Mohyuddin

56PUBLICATIONS
85CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromoleculesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jul 14, 2026
Ciltacabtagene autoleucel heralds the arrival of fixed-duration therapies in myeloma.

|Jun 09, 2026
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma.

|Jun 08, 2026
Does ciltacabtagene autoleucel have a future in multiple myeloma?

|May 01, 2026
The Association of Age and Frailty With Adverse Events for Bortezomib and Carfilzomib: A Population-Based Analysis.

|Apr 17, 2026
Improving control arms in 2026 US myeloma trials.

|Feb 26, 2026
Patients', clinicians' and research's priorities on important outcomes in multiple myeloma: A mixed-methods study.

Maria Mainou, Thomas Karagiannis, Eirini Pagkalidou

Pageof 10

Frequent Collaborators

13 joint publications

Rajshekhar Chakraborty

11 joint publications

Edward R Scheffer Cliff

7 joint publications

Meera Mohan

6 joint publications

Douglas W Sborov